OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis
These results indicate that OCIAD2 is a potential prognostic biomarker and therapeutic target for PC patients.
Authors
- Zhongyuan Cui (ORCID: https://orcid.org/0000-0001-9476-9870)
- Zhixian Wu (ORCID: https://orcid.org/0000-0002-0708-6770)
- Yani Gou
- Xiaojun Huang
- Lei Xia (ORCID: https://orcid.org/0000-0001-9749-3435)
Institutions
- Xiamen University (CN)
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- PLoS Computational Biology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1371/journal.pcbi.1013566
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00